HG-1161

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameHG-1161

Drug Alias NameC-type lectin BIMLEC modulator (Human Genome Sciences)DCL-1 modulator (Human Genome Sciences)HMCEH49 modulator (Human Genome Sciences)type I transmembrane C-type lectin receptor DCL-1 modulator (Human Genome Sciences)BIMLEC modulator (Human Genome Sciences) +[7]

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionC-type lectins modulators

TargetsC-type lectins

Therapy Area/Indications +[1] N/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesHuman Genome Sciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesHuman Genome Sciences Inc

Active IndicationsN/A

Inactive Indications +[1] N/A

Other Information

ATC CodeN/A